Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP19A1 | P11511 | 8/20 | 0.67 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | RAB9A | P51151 | 1/20 | 0.42 |
| ▸ | CYP1A1 | P04798 | 1/20 | 0.42 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.41 |
| ▸ | ATP4A | P20648 | 1/20 | 0.40 |
| ▸ | ATP4B | P51164 | 1/20 | 0.40 |
| ▸ | PADI4 | Q9UM07 | 1/20 | 0.40 |
| ▸ | GSK3A | P49840 | 1/20 | 0.40 |
| ▸ | GSK3B | P49841 | 1/20 | 0.40 |
| ▸ | MGLL | Q99685 | 1/20 | 0.40 |
| ▸ | HRH3 | Q9Y5N1 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3113486 | 0.89 | CYP19A1 (0.62) | CYP19A1ATP4AATP4BGSK3AGSK3B | |
| SCHEMBL6760653 | 0.87 | CYP19A1 (0.61) | CYP19A1ATP4AATP4BGSK3AGSK3B | |
| SCHEMBL30168324 | 0.86 | CYP19A1 (0.59) | CYP19A1ATP4AATP4BGSK3AGSK3B | |
| SCHEMBL15051376 | 0.81 | GFER (0.45) | CYP19A1NPC1RAB9A | |
| SCHEMBL155247 | 0.80 | CYP19A1 (1.00) | CYP19A1MAPTCYP1A1 | |
| SCHEMBL17300465 | 0.80 | HRH3 (0.50) | CYP19A1HRH3 | |
| Hydrochloric Acid SCHEMBL7263772 | 0.78 | CYP19A1 (0.96) | CYP19A1MAPTCYP1A1 | |
| SCHEMBL930156 | 0.78 | CYP19A1 (0.57) | CYP19A1CYP1A1ATP4AATP4BPADI4 | |
| SCHEMBL6580252 | 0.76 | HMOX1 (0.54) | CYP19A1NPC1MAPTRAB9AATP4A | |
| SCHEMBL6582554 | 0.75 | HMOX1 (0.53) | CYP19A1NPC1MAPTRAB9AATP4A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 21 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0842158-A1 | MICROBICIDAL 2-PHENYLETHYL-MERCAPTO-TRIAZOLES | BAYER AG (DE) | 1998-05-20 | — | — | EP | claimed |
| WO-1997005119-A1 | MICROBICIDAL 2-PHENYLETHYL-MERCAPTO-TRIAZOLES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-02-13 | — | — | WO | claimed |
| EP-0000017-B1 | 1-(2-PHENYLETHYL)-TRIAZOLIUM SALTS, THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER AG (DE) | 1981-09-30 | — | — | EP | claimed |
| CN-116444380-B | Method for realizing amino derivative alkylation by utilizing micro-flow field technology | 南京工业大学 | 2024-09-17 | — | — | CN | disclosed |
| CN-116444380-A | Method for realizing amino derivative alkylation by utilizing micro-flow field technology | 南京工业大学 | 2023-07-18 | — | — | CN | disclosed |
| CN-111285850-B | Isoindoline compounds, preparation method thereof, pharmaceutical composition and application thereof | 中国科学院上海药物研究所 | 2022-04-22 | — | — | CN | disclosed |
| CN-103717578-B | Fungicidal substituted 1- {2- [ 2-halo-4- (4-halophenoxy) phenyl ] -2-ethoxyethyl } -1H- [1,2,4] triazole compounds | 巴斯夫欧洲公司 | 2016-12-21 | — | — | CN | disclosed |
| EP-2744793-B1 | FUNGICIDAL SUBSTITUTED 1-{2-[2-HALO-4-(4-HALOGEN-PHENOXY)-PHENYL]-2-ETHOXY-ETHYL}-1H- [1,2,4]TRIAZOLE COMPOUNDS | BASF SE (DE) | 2015-10-14 | — | — | EP | disclosed |
| EP-2744793-A1 | FUNGICIDAL SUBSTITUTED 1-{2-[2-HALO-4-(4-HALOGEN-PHENOXY)-PHENYL]-2-ETHOXY-ETHYL}-1H- [1,2,4]TRIAZOLE COMPOUNDS | BASF SE (DE) | 2014-06-25 | — | — | EP | disclosed |
| US-20140162876-A1 | Fungicidal substituted 1--1H-[1,2,4]triazole compounds | BASF SE (DE) | 2014-06-12 | — | — | US | disclosed |
| CN-103717578-A | Fungicidal substituted 1- {2- [ 2-halo-4- (4-halophenoxy) phenyl ] -2-ethoxyethyl } -1H- [1,2,4] triazole compounds | BASF SE | 2014-04-09 | — | — | CN | disclosed |
| US-20040106803-A1 | Production method of 1-substituted-1,2,3-triazole derivatives | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2004-06-03 | — | — | US | disclosed |
| US-6743924-B2 | EFFICIENT, HIGH YEILD SYNTHESIS OF TYROSINE KINASE INHIBITORS | TAKEDA CHEMICAL INDUSTRIES, LTD. (JP) | 2004-06-01 | — | — | US | disclosed |
| EP-1310491-A1 | METHOD FOR PRODUCING 1-SUBSTITUTED-1,2,3-TRIAZOLE DERIVATIVE | Takeda Chemical Industries, Ltd. (JP) | 2003-05-14 | — | — | EP | disclosed |
| US-20030069419-A1 | Method for producing 1-substituted-1,2,3- triazole derivative | TAKEDA PHARMACEUTICAL COMPANY, LIMITED (JP) | 2003-04-10 | — | — | US | disclosed |
| EP-0842158-A1 | MICROBICIDAL 2-PHENYLETHYL-MERCAPTO-TRIAZOLES | BAYER AG (DE) | 1998-05-20 | — | — | EP | disclosed |
| WO-1997005119-A1 | MICROBICIDAL 2-PHENYLETHYL-MERCAPTO-TRIAZOLES | BAYER AKTIENGESELLSCHAFT (DE) | 1997-02-13 | — | — | WO | disclosed |
| EP-0000017-B1 | 1-(2-PHENYLETHYL)-TRIAZOLIUM SALTS, THEIR PREPARATION AND THEIR USE AS FUNGICIDES | BAYER AG (DE) | 1981-09-30 | — | — | EP | disclosed |
| EP-0000017-A1 | 1-(2-Phenylethyl)-triazolium salts, their preparation and their use as fungicides | BAYER AG (DE) | 1978-12-20 | — | — | EP | disclosed |
| EP-0000017-A1 | 1-(2-Phenylethyl)-triazolium salts, their preparation and their use as fungicides | BAYER AG (DE) | 1978-12-20 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140162876-A1 | Fungicidal substituted 1--1H-[1,2,4]triazole compounds | CYP51A1, CYP1B1, CYP1A1 | CYP19A1 391/4885NPC1 603/4885MAPT 1970/4885 |
| US-20040106803-A1 | Production method of 1-substituted-1,2,3-triazole derivatives | ABL1, ROS1, ADH1A | CYP19A1 647/4885NPC1 4224/4885MAPT 2311/4885 |
| US-20030069419-A1 | Method for producing 1-substituted-1,2,3- triazole derivative | ABL1, YES1, MAP3K1 | CYP19A1 686/4885NPC1 4265/4885MAPT 2295/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.